Massachusetts Voters Reject Psychedelic Decriminalization Initiative

The ballot measure to decriminalize five natural psychedelics was rejected by a significant margin, reflecting concerns over safety and regulation.

Question 4 proposed decriminalizing psilocybin, psilocyn, DMT, ibogaine, and mescaline for adults 21 and over in Massachusetts.
The initiative also aimed to establish state-licensed psychedelic therapy centers, similar to measures in Oregon and Colorado.
Opponents raised concerns about the lack of medical oversight and potential public safety risks, including drugged driving and accidental ingestion.
Proponents emphasized the therapeutic potential of psychedelics for mental health issues, but acknowledged home growth provisions were controversial.
Despite the rejection, supporters plan to continue advocating for legislative changes to improve access to psychedelic therapies.